Development stage

1-2

Assets whose furthest-along trial is at this stage.

CWP232291
Unknown / undisclosedPhase 1/2
DS-1103a
Unknown / undisclosedPhase 1/2
TE-8105
PeptidePhase 1/2
VX-264
Cell therapyPhase 1/2

← all assets